Neurovascular Embolization Devices Market Top Companies Study - Acandis GmBH, B. Braun, BALT Extrusion, Emboflu, Stryker, Johnson & Johnson.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Neurovascular Embolization Devices Market- by Product Type (Aneurysm Clips, Liquid Embolic Systems, Flow Diversion Stents, Embolization Coils and Intrasaccular Flow Disruptors), End-Users (Hospitals, Ambulatory Surgical Centers and Specialty Clinics), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the global Neurovascular Embolization Devices market is valued at USD 1.44 Billion in 2023, and it is expected to reach USD 2.41 Billion by the year 2031, with a CAGR of 6.75% during a forecast period of 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1055

Neurovascular embolization devices are employed in the treatment of abnormal blood vessel formations in the brain, such as brain aneurysms and arteriovenous malformations. These devices function by obstructing or terminating blood flow to undesirable vascular abnormalities. The primary types of neurovascular embolization devices include intrasaccular flow disruptors, liquid embolic systems, aneurysm clips, flow diversion stents, and embolization coils. Embolization coils are the most widely used treatment for brain aneurysms, followed by aneurysm clamps and flow diversion stents. Embolization coils are implanted into the aneurysm sac to restrict blood flow and promote thrombosis under medical supervision. Post-procedural follow-up imaging is often required, as residual filling or recurrence of the aneurysm can increase the risk of delayed hemorrhage.

The global market for neurovascular embolization devices is expected to grow due to the presence of a substantial target patient population, ongoing product innovation and commercialization, and favorable medical reimbursement policies. Market expansion is further supported by advancements in healthcare infrastructure in developing economies and the increasing demand for effective neurovascular treatment options. Leading market players are focusing on product launches and strategic acquisitions to strengthen their market position. Additionally, growing research in neurovascular treatments and the increasing preference for minimally invasive neurosurgical procedures are anticipated to create new market opportunities.

Despite the positive growth outlook, the market for neurovascular embolization devices is expected to face certain challenges. Stringent regulatory requirements and a shortage of skilled neurosurgeons may impede market expansion in the coming years.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-03

North America is projected to be the largest contributor to the neurovascular embolization devices market during the forecast period, driven by the high concentration of key market players and the increasing prevalence of neurovascular disorders in the region. Furthermore, the Asia-Pacific market is anticipated to experience significant growth due to rising awareness of innovative neurovascular treatments, a large patient population, and increasing healthcare expenditure. These factors are expected to drive market growth in the region over the forecast period.

Major market players operating in the Neurovascular Embolization Devices market include
Acandis GmBH, B. Braun, Johnson & Johnson (Cerenovus), KLS Martin, BALT Extrusion, Emboflu, Stryker, Medtronic Plc, Mizuho Medical, Phenox GmBH, Spartan Micro, Peter Lazic GmBH, Terumo Corporation (MicroVention) among others.

Recent collaborations and agreements in the market:
• In February 2021, for the recently acquired radial artery access portfolio from RIST Neurovascular, Inc., Medtronic announced an increase in its limited site release.
• In January 2021, in order to expand their neurovascular business in China, Genesis MedTech Group and Penumbra, Inc. launched a strategic alliance. To establish a neurovascular franchise, the company has opted to complete the purchase of Hua MedTech.
• In December 2020, the intrasaccular aneurysm therapeutic device WEB embolization system from Terumo Corporation was made available in Japan.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1055

Market Segments
Global Neurovascular Embolization Devices Market, by Product Type, 2022-2030 (Value US$ Mn)
• Aneurysm Clips
• Liquid Embolic Systems
• Flow Diversion Stents
• Embolization Coils
• Intrasaccular Flow Disruptors
Global Neurovascular Embolization Devices Market, by End-Users, 2022-2030 (Value US$ Mn)
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
Global Neurovascular Embolization Devices Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Neurovascular Embolization Devices Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Neurovascular Embolization Devices Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Neurovascular Embolization Devices Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Neurovascular Embolization Devices Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Neurovascular Embolization Devices Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
• To receive a comprehensive analysis of the prospects for the global Neurovascular Embolization Devices market
• To receive an industry overview and future trends of the Neurovascular Embolization Devices market
• To analyze the Neurovascular Embolization Devices market drivers and challenges
• To get information on the Neurovascular Embolization Devices market value (US$Mn) forecast to 2030
• Significant investments, mergers & acquisitions in the Neurovascular Embolization Devices market industry

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.